• Molecular NameZolpidem
  • SynonymZolpidem tartrate; Zolpidemum [Latin]
  • Weight363.505
  • Drugbank_IDDB00425
  • ACS_NO82626-48-0
  • Show 2D model
  • LogP (experiment)3.85
  • LogP (predicted, AB/LogP v2.0)4.45
  • pka6.2
  • LogD (pH=7, predicted)4.41
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.3
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds7
  • TPSA38.13
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA prescription medication used for the short-term treatment of insomnia, as well as some brain disorders.
  • Absorption_value95.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability72.0
  • Protein binding92.0
  • Volume of distribution (VD)0.68 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmMetabolically cleared predominantly by CYP3A4.
  • Half life1.9 h
  • Excretion56% renal, 34% fecal
  • Urinary Excretion<1
  • Clerance4.5 ml/min/kg
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A